Blood oxygen level-dependent signal feedback for brain activity regulation via operant conditioning (BOLD signal feedback (for brain activity regulation))

The term "Brain activity regulation via operant conditioning using BOLD signal feedback" refers to the use of real-time blood oxygen level-dependent (BOLD) functional magnetic resonance imaging (fMRI) signals as a form of **neurofeedback**. In this approach, individuals receive immediate information about their own brain activation patterns—measured by changes in the BOLD signal—and are trained through operant conditioning to modulate their neural activity intentionally. The **BOLD signal** itself is an indirect measure of neuronal activation. It reflects changes in local blood flow and oxygenation that occur when neurons become active and consume more energy. This increased demand leads to an overcompensating rise in cerebral blood flow, which increases the ratio of oxygenated to deoxygenated hemoglobin; these changes alter the magnetic properties detected by MRI scanners[1][2][4]. The physiological basis involves complex interactions between neurons, astrocytes, vascular cells, and metabolic processes[2][7]. In **operant conditioning with BOLD feedback**, subjects attempt to control specific aspects of their own brain function—such as increasing or decreasing activation within targeted regions—by observing real-time visual or auditory representations derived from their ongoing fMRI data. Over repeated sessions, some individuals can learn voluntary self-regulation strategies that may influence cognition or behavior. This method is used experimentally for research into cognitive neuroscience and has been explored as a potential intervention for conditions such as depression or chronic pain. However, it does not represent a molecular target like a receptor or enzyme but rather describes an experimental technique leveraging physiological signals at the systems neuroscience level. Because this entry describes an *experimental method* rather than a discrete molecular entity or therapeutic target classically defined in pharmacology/biology databases—and because it combines both mechanism ("brain activity regulation") and technology ("operant conditioning using BOLD")—it should be flagged as incorrect if strict molecular targeting is required. > The BOLD response is shaped by integration between local metabolism/oxygen use and vascular supply; its interpretation requires understanding contributions from multiple cell types including neurons and glia[2]. The relationship between actual neuronal firing/spiking versus what is measured with the BOLD response can be complex; factors such as neurovascular coupling variability may confound results[3][6]. No drugs directly interact with this "target," nor are there established biomarkers specific for patient selection beyond those used generally in fMRI studies. Safety concerns relate primarily to misinterpretation due to indirectness/noise/artifacts inherent in hemodynamic-based measurements rather than pharmacological toxicity. In summary: This entry does not correspond to any canonical molecule/receptor/enzyme but instead refers broadly to an experimental neuromodulation technique based on real-time analysis/feedback from hemodynamic imaging data.

Other names

BOLD neurofeedbackReal-time fMRI neurofeedbackOperant conditioning of brain activity using BOLD signalBrain self-regulation via fMRI